slow weight loss on semaglutide Losers Semaglutide (Ozempic® & Wegovy®) Before
Description
Biochem J 362:389394
Glucagon-like peptide-1 agonists, or GLP-1s, are prescription drugs that were first authorized to treat type 2 diabetes
Plasma AST (Figure 7A) and ALT (Figure 7B) significantly decreased in all treatment groups and were maintained at decreased levels during follow-up
These data suggest that the weight loss plateau and rapid weight regain after discontinuation of treatment may be caused by reductions in NREE
